Page last updated: 2024-08-17

n,n-dimethyltryptamine and Basal Ganglia Diseases

n,n-dimethyltryptamine has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schöpf, J1

Other Studies

1 other study(ies) available for n,n-dimethyltryptamine and Basal Ganglia Diseases

ArticleYear
[Biogenic amines and schizophrenia].
    Schweizerische medizinische Wochenschrift, 1975, Sep-20, Volume: 105, Issue:38

    Topics: Amphetamines; Basal Ganglia Diseases; Clozapine; Dopamine; Dopamine beta-Hydroxylase; Humans; N,N-Dimethyltryptamine; Parkinson Disease, Secondary; Receptors, Adrenergic; Schizophrenia; Tranquilizing Agents

1975